Literature DB >> 9252363

Specific binding of the chemokine platelet factor 4 to heparan sulfate.

S E Stringer1, J T Gallagher.   

Abstract

Platelet factor 4 is a tetrameric heparin binding chemokine released from the alpha-granules of activated platelets. In this study we show that platelet factor 4 binds with high affinity and specificity to an approximately 9-kDa sequence in heparan sulfate, which it protects from degradation by heparinase enzymes. This protected fragment is enriched in N-sulfated disaccharides and iduronate 2-O-sulfate residues, the latter being important for binding to platelet factor 4. The major structural motif of the fragment appears to consist of a pair of sulfated domains positioned at both ends separated by a central mainly N-acetylated region. On the basis of these findings, we propose a model in which the heparan sulfate fragment wraps around the ring of positive charges on platelet factor 4 with the iduronate 2-O-sulfates within the sulfated domains binding strongly to lysine clusters on opposite faces of the tetramer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252363     DOI: 10.1074/jbc.272.33.20508

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

Review 1.  Heparan sulfate: growth control with a restricted sequence menu.

Authors:  J T Gallagher
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometry.

Authors:  Hicham Naimy; Nancy Leymarie; Joseph Zaia
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

3.  Chemoenzymatic synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities.

Authors:  Yongmei Xu; Elizabeth H Pempe; Jian Liu
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

Review 4.  Glycoscience finally comes of age.

Authors:  Anthony H Merry; Catherine L R Merry
Journal:  EMBO Rep       Date:  2005-10       Impact factor: 8.807

5.  Disruption of PF4/H multimolecular complex formation with a minimally anticoagulant heparin (ODSH).

Authors:  M V Joglekar; P M Quintana Diez; S Marcus; R Qi; B Espinasse; M R Wiesner; E Pempe; J Liu; D M Monroe; G M Arepally
Journal:  Thromb Haemost       Date:  2012-02-08       Impact factor: 5.249

6.  FGF-FGFR signaling mediated through glycosaminoglycans in microtiter plate and cell-based microarray platforms.

Authors:  Eric Sterner; Luciana Meli; Seok-Joon Kwon; Jonathan S Dordick; Robert J Linhardt
Journal:  Biochemistry       Date:  2013-12-06       Impact factor: 3.162

7.  Coacervate delivery of HB-EGF accelerates healing of type 2 diabetic wounds.

Authors:  Noah R Johnson; Yadong Wang
Journal:  Wound Repair Regen       Date:  2015-07-27       Impact factor: 3.617

8.  Effects of sulfate position on heparin octasaccharide binding to CCL2 examined by tandem mass spectrometry.

Authors:  Matt D Sweeney; Yonghao Yu; Julie A Leary
Journal:  J Am Soc Mass Spectrom       Date:  2006-06-02       Impact factor: 3.109

Review 9.  Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development.

Authors:  Valerie A Wilson; John T Gallagher; Catherine L R Merry
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

10.  Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells.

Authors:  Gerald Misinzo; Peter L Delputte; Peter Meerts; David J Lefebvre; Hans J Nauwynck
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.